Patients should ask their clinician for personalised advice, particularly if they have diabetes, pancreatitis risk, liver disease or significant gastrointestinal side effects
doi: 10.1016/j.micres.2019.126388 30 ChandraD.SrivastavaR.GlickB
Add-on Combination Therapy with Metformin A total of 701 patients with type 2 diabetes mellitus participated in a 24-week, randomized, double-blind, placebo-controlled trial designed to assess the efficacy of sitagliptin in combination with metformin
Acute pancreatitis, gallbladder illness, and hypoglycemia are rare yet serious Semaglutide adverse effects
Not only is there no added benefit, but because they belong to the same class of drugs, you run the risk of double-dosing